Oramed Pharmaceuticals (ORMP) Earnings Date & Reports

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

ORMP is expected to report earnings to fall 89.67% to 18 cents per share on November 16

Oramed Pharmaceuticals ORMP Stock Earnings Reports

Q3'26

Est.

$0.19

Q2'26

Beat

by $1.69

Q4'25

Beat

by $0.08

Q3'25

Beat

by $0.19

Q2'25

Missed

by $0.03

The last earnings report on August 24 showed earnings per share of $1.84, beating the estimate of 15 cents. With 84.12K shares outstanding, the current market capitalization sits at 200.08M.

View a ticker or compare two or three

Ask AI

Compare

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

Annualized Return+18%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

ORMP

Setup

Daily Signal:

Description

Gain/Loss: